You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 11, November 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Gene therapy for neurologic disease

S. T. Suhr and F. H. Gage
Department of Neurosciences, University of California, San Diego.

Gene therapy is a potentially potent new method of treating a number of neurologic disorders previously considered refractory to current conventional therapeutic treatments. Numerous advances have been made in the construction of expression vectors, cellular and viral transgene carriers, and the characterization of target cells for neuronal gene therapy. Two primary approaches to nervous system gene transfer have emerged as a result of these advances. The in vivo approach concentrates on direct transfer of genetic material to cells in vivo using viral and chemical agents. The ex vivo approach relies on genetic transfer to cultured cells that are subsequently implanted into a host organism. Both of these methods have been used in preliminary experiments designed to test the efficacy of gene transfer strategies in the amelioration of nervous system dysfunction.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of Growth of Human Prostate Cancer Xenograft by Transfection of p53 Gene: Gene Transfer by Electroporation
Mikata et al.
Molecular Cancer Therapeutics 2002;1:247-252.
ABSTRACT | FULL TEXT  

Gene Therapy for Lysosomal Storage Disorders with Neuropathology
IOANNOU
J. Am. Soc. Nephrol. 2000;11:1542-1547.
FULL TEXT  

Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain Barrier
Fenart et al.
J. Pharmacol. Exp. Ther. 1999;291:1017-1022.
ABSTRACT | FULL TEXT  

Gene Therapy in the Central Nervous System: The Use of Recombinant Retroviruses
Suhr and Gage
Arch Neurol 1999;56:287-292.
FULL TEXT  

Review : Gene Therapy: Applications to the Neurosciences and to Neurological Disease
Tuszynski
Neuroscientist 1998;4:398-407.
ABSTRACT  

Review : Neural Stem-Like Cells: Developmental Lessons with Therapeutic Potential
Snyder
Neuroscientist 1998;4:408-425.
ABSTRACT  

Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 2. The Bedside
Maria et al.
J Child Neurol 1997;12:77-84.
ABSTRACT  

Noninvasive gene targeting to the brain
Shi and Pardridge
Proc. Natl. Acad. Sci. USA 2000;97:7567-7572.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.